Search results
Constantly on the hunt for food: Harbor porpoises more vulnerable than previously thought to...
Phys.org· 5 days agoIn general, people relax and have a good time on the water, but that is unfortunately not the case...
Constantly on the hunt for food: Harbor porpoises more vulnerable than previously thought
Science Daily· 6 days agoIn general people relax and have a good time on the water, but that is unfortunately not the case for the harbor porpoise. The more motor boats speeding noisily around, the more they are disturbed ...
Urology pearls – classic
The Mining Journal· 17 hours agoAt one point in my life, when I lived on Mount Carmel, Israel, it would have taken me about 15 minutes to drive to his home. My goal wasn’t to describe...
World's first bioprocessor uses 16 human brain organoids for ‘a million times less power’...
Tom's Hardware via Yahoo News· 2 days agoA Swiss biocomputing startup has launched an online platform that provides remote access to 16 human...
Europe Can Reap Sizable Energy Security Rewards by Scaling Up Climate Action
IMF· 15 hours agoRussia’s invasion of Ukraine triggered Europe’s worst energy crisis since the 1970s and put energy security back at the top of the policy agenda. Policymakers reacted swiftly by securing alternative ...
Why high-quality Urolithin A is the future health longevity essential
Nutraingredients.com· 1 day agoUrolithin A is a metabolite with profound health benefits and potential longevity effects.
cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions
Digital Journal· 4 days agoCharlotte, North Carolina--(Newsfile Corp. - May 24, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company") is thrilled to announce the launch of its highly anticipated ...
World's first bioprocessor uses 16 human brain organoids for ‘a million times less power’...
Tom s Hardware· 2 days agoA Swiss biocomputing startup has launched an online platform that provides remote access to 16 human...
NeuroBo Pharmaceuticals' DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and...
WRBL Columbus· 6 days agoNeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that pre-clinical data suggests ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days agoSTOCKHOLM, Sweden, May 24, 2024 (GLOBE NEWSWIRE) -- Atrogi, a pioneering clinical-stage biotech company advancing treatments for metabolic disorders, announces a publication in the Journal of Molecular Metabolism (1). The research paper validates
